Skip to main content

Solid Lipid Nanoparticles Containing Berberine by Spray-Drying Method

  • Conference paper
  • First Online:
8th International Conference on the Development of Biomedical Engineering in Vietnam (BME 2020)

Abstract

Berberine is commonly used in Eastern countries due to its various biological activities and low cost. However, low permeability has limited its bioavailability. This study was conducted to fabricate solid lipid nanoparticles (SLNs) containing berberine by spray-drying method to enhance its absorption in the human body. SLNs containing berberine was prepared by stearic acid as a solid lipid base and various surfactants. Then, the aqueous dispersion of SLNs was converted into powders to be stored over a long time by the spray-drying method with carbohydrate carriers. The spray-drying parameters such as the inlet and outlet temperatures, the blower speed, the atomizing pressure, the feeding rate were optimized. The nanoparticles physicochemical properties were evaluated before and after the spraying process. The lipid nanoparticles containing berberine were successfully prepared by the spray-drying method with a small particle size (around 230 nm), zeta potential (approximately −30 mV), and homogenous dispersion (polydispersity index just above 0.12). The optimized spray drying parameters were Tinlet/outlet of 110/65 °C, the blower of 0.58 m3/min, atomizing of 20 kPa, and feeding rate of 0.1 L/h. The resulted SLNs exhibited good physical stability and redispersion. The collected SLNs by spray-drying could be considered a potential drug delivery system to enhance berberine absorption into our human body.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 219.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 279.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Mehnert W, Mader K (2012) Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev 64:83–101

    Article  Google Scholar 

  2. Freitas C, Muller RH (1999) Correlation between long-term stability of solid lipid nanoparticles (SLNTM) and crystallinity of the lipid phase. Eur J Pharm Biopharm 47(2):125–132

    Article  Google Scholar 

  3. Muller RH, Runge SA (1998) Solid lipid nanoparticles (SLN) for controlled drug delivery. Submicron Emulsions Drug targeting Delivery 22:219–234

    Google Scholar 

  4. Eldem T, Speiser P, Hincal A (1991) Optimization of spray-dried and congealed lipid micropellets and characterization of their surface morphology by scanning electron microscopy. Pharm Res 8(1):47–51

    Article  Google Scholar 

  5. Speiser P (1990) Lipidnanopellets als Trägersystem für Arzneimittel zur peroralen Anwendung. European Patent EP 167825, 0167825

    Google Scholar 

  6. Muller RH, Shegokar R, Keck MC (2011) 20 years of lipid nanoparticles (SLN & NLC): present state of development & industrial applications. Curr Drug Discovery Technol 8(3):207–227

    Google Scholar 

  7. Beloqui A, Solinís MA, Delgado A, Evora C, del Pozo-Rodríguez A, Rodríguez Gascón A (2013) Biodistribution of nanostructured lipid carriers (NLCs) after intravenous administration to rats: influence of technological factors. Eur J Pharm Biopharm 84(2):309–314

    Google Scholar 

  8. Beloqui A, Solinís MÁ, Gascón AR, del Pozo-Rodríguez A, des Rieux A, Préat V (2013) Mechanism of transport of saquinavir-loaded nanostructured lipid carriers across the intestinal barrier. J Controlled Release 166(2):115–123

    Google Scholar 

  9. Keck CM, Hommoss A, Muller RH (2008) Lipid nanoparticles (SLN, NLC, LDC) for the enhancement of oral absorption. In: Walker RB, Hadgraft J, Roberts MS, Lane ME (eds) Modified release drug delivery systems, vol 1, 2nd ed, pp 269–286

    Google Scholar 

  10. Müller RH, Mäder K, Gohla S (2000) Solid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the art. Eur J Pharm Biopharm 50(1):161–177

    Article  Google Scholar 

  11. Corrias F, Lai F (2011) New methods for lipid nanoparticles preparation. Recent Pat Drug Deliv Formul 5(3):201–213

    Article  Google Scholar 

  12. Ricci M, Puglia C, Bonina F, Di Giovanni C, Giovagnoli S, Rossi C (2005) Evaluation of indomethacin percutaneous absorption from nanostructured lipid carriers (NLC): in vitro and in vivo studies. J Pharm Sci 94(5):1149–1159

    Article  Google Scholar 

  13. Freitas C, Lucks JS, Müller RH (1994) P238 effect of storage conditions on long-term stability of “solid lipid nanoparticles” (SLN) in aqueous dispersion. Eur J Pharm Sci 2(1–2):178

    Article  Google Scholar 

  14. Broadhead J, Edmond Rouan SK, Rhodes CT (1992) The spray drying of pharmaceuticals. Drug Dev Ind Pharm 18(11–12):1169–1206

    Article  Google Scholar 

  15. Freag MS, Saleh WM, Abdallah OY (2018) Laminated chitosan-based composite sponges for transmucosal delivery of novel protamine-decorated tripterine phytosomes: ex-vivo mucopenetration and in-vivo pharmacokinetic assessments. Carbohyd Polym 188:108–120

    Article  Google Scholar 

  16. Yu F, Ao M, Zheng X, Li N, Xia J, Li Y et al (2017) PEG–lipid–PLGA hybrid nanoparticles loaded with berberine–phospholipid complex to facilitate the oral delivery efficiency. Drug Deliv 24(1):825–833

    Google Scholar 

  17. Spinozzi S, Colliva C, Camborata C, Roberti M, Ianni C, Neri F et al (2014) Berberine and its metabolites: relationship between physicochemical properties and plasma levels after administration to human subjects. J Nat Prod 77(4):766–772

    Google Scholar 

  18. Battu SK, Repka MA, Maddineni S, Chittiboyina AG, Avery MA, Majumdar S (2010) Physicochemical characterization of berberine chloride: a perspective in the development of a solution dosage form for oral delivery. AAPS PharmSciTech 11(3):1466–1475

    Article  Google Scholar 

  19. Imanshahidi M, Hosseinzadeh H (2008) Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine. Phytother Res 22(8):999–1012

    Article  Google Scholar 

  20. Singh T, Vaid M, Katiyar N, Sharma S, Katiyar SK (2011) RETRACTED: Berberine, an isoquinoline alkaloid, inhibits melanoma cancer cell migration by reducing the expressions of cyclooxygenase-2, prostaglandin E2and prostaglandin E2receptors. Carcinogenesis 32(1):86–92

    Article  Google Scholar 

  21. Birdsall TC (1997) Berberine: therapeutic potential of alkaloid found in several medicinal plants. Altern Med Rev 2:94–103

    Google Scholar 

  22. Kulkarni SK, Dandiya PC, Varandani NL (1972) Pharmacological investigations of berberine sulphate. Jpn J Pharmacol 22(1):11–16

    Article  Google Scholar 

  23. Huang CG, Chu ZL, Yang ZM (1991) Effects of berberine on synthesis of platelet TXA2 and plasma PGI2 in rabbits. Zhongguo yao li xue bao Acta pharmacologica Sinica 12(6):526

    Google Scholar 

  24. Salminen H, Ankenbrand J, Zeeb B, Bönisch GB, Schäfer C, Kohlus R, Weiss J (2019) Influence of spray drying on the stability of food-grade solid lipid nanoparticles. Food Res Int 119:741–750

    Article  Google Scholar 

  25. Qsonica. Sonicator ultrasonic processor operation manual. https://cdn.shopify.com/s/files/1/1726/3473/files/q700-manual.pdf?

  26. Eskandarloo H, Badiei A, Behnajady MA, Ziarani GM (2016) Ultrasonic-assisted degradation of phenazopyridine with a combination of Sm-doped ZnO nanoparticles and inorganic oxidants. Ultrason Sonochem 28:169–177

    Article  Google Scholar 

  27. Hao H, Wu M, Chen Y, Tang J, Wu Q (2004) Cavitation mechanism in cyanobacterial growth inhibition by ultrasonic irradiation. Colloids Surf, B 33(3–4):151–156

    Article  Google Scholar 

  28. Panariti A, Miserocchi G, Rivolta I (2012) The effect of nanoparticle uptake on cellular behavior: disrupting or enabling functions? Nanotechnol Sci Appl 5:87

    Google Scholar 

  29. Rejman J, Oberle V, Zuhorn IS, Hoekstra D (2004) Size-dependent internalization of particles via the pathways of clathrin-and caveolae-mediated endocytosis. Biochem J 377(1):159–169

    Article  Google Scholar 

  30. Müller RH, Mehnert W, Lucks JS, Schwarz C, Zur Mühlen A (1995) Solid lipid nanoparticles (SLN): an alternative colloidal carrier system for controlled drug delivery. Eur J Pharm Biopharm 41(1):62–69

    Google Scholar 

  31. Mudalige T, Qu H, Van Haute D, Ansar SM, Paredes A, Ingle T (2019) Characterization of nanomaterials: tools and challenges. In: Nanomaterials for food applications. Elsevier, Amsterdam, pp 313–353

    Google Scholar 

  32. Jain R, Savla H, Naik I, Maniar J, Punjabi K, Vaidya S, Menon M (2018) Novel nanotechnology based delivery systems for chemotherapy and prophylaxis of tuberculosis. In: Handbook of nanomaterials for industrial applications. Elsevier, Amsterdam, pp 587–620

    Google Scholar 

  33. Fang JY, Fang CL, Liu CH, Su YH (2008) Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC). Eur J Pharm Biopharm 70(2):633–640

    Article  Google Scholar 

  34. Müller RH, Radtke M, Wissing SA (2002) Nanostructured lipid matrices for improved microencapsulation of drugs. Int J Pharm 242(1–2):121–128

    Article  Google Scholar 

  35. Freitas C, Müller RH (1998) Spray-drying of solid lipid nanoparticles (SLNTM). Eur J Pharm Biopharm 46(2):145–151

    Article  Google Scholar 

Download references

Acknowledgements

This research is funded by International University, Vietnam National University Ho Chi Minh City under grant number: SV2019-BME-09/HĐ-KHCN.

This research is funded by Vietnam National University HoChiMinh City (VNU-HCM) under grant number NCM2020-28-01”.

Conflicts of Interest

The authors have no conflicts of interest to declare.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Van Hong Nguyen .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2022 Springer Nature Switzerland AG

About this paper

Check for updates. Verify currency and authenticity via CrossMark

Cite this paper

Nguyen, M.CN., Le, K.NM., Huynh, N.TT., Nguyen, T.TT., Bui, H.TX., Nguyen, V.H. (2022). Solid Lipid Nanoparticles Containing Berberine by Spray-Drying Method. In: Van Toi, V., Nguyen, TH., Long, V.B., Huong, H.T.T. (eds) 8th International Conference on the Development of Biomedical Engineering in Vietnam. BME 2020. IFMBE Proceedings, vol 85. Springer, Cham. https://doi.org/10.1007/978-3-030-75506-5_25

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-75506-5_25

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-75505-8

  • Online ISBN: 978-3-030-75506-5

  • eBook Packages: EngineeringEngineering (R0)

Publish with us

Policies and ethics